Quote Of The Year

Timeless Quotes - Sadly The Late Paul Shetler - "Its not Your Health Record it's a Government Record Of Your Health Information"

or

H. L. Mencken - "For every complex problem there is an answer that is clear, simple, and wrong."

Friday, August 22, 2025

Iron Deficiency Is A Very Serious And An Under Recognized Problem In Young Women

This appeared last week:

More awareness is vital to say the least:

Gaslit, dismissed and treated as hypochondriacs: The gender divide in iron deficiency

By Kate Aubusson

August 16, 2025

Iron-deficient and anaemic women are being gaslit and denied effective treatment, while pathology companies systematically report “normal” blood test results for females who would be diagnosed with iron deficiency if they were male.

Among the more than 2000 women who shared accounts of medical misogyny with this masthead were more than 50 women with debilitating iron deficiency or anaemia who were treated as hypochondriacs or had their symptoms dismissed by healthcare professionals, including one woman whose haemoglobin count was that of a traumatic car crash victim.

Other women described their heavy menstrual bleeding being written off as a normal, untreatable part of womanhood, and experiencing damaging delays in investigating serious underlying causes of their low iron. Iron is an essential mineral for organ function, from carrying oxygen in red blood cells, to immune and brain health.

Some of Australia’s biggest pathology providers have for years set a significantly lower benchmark for what they consider “normal” iron stores in females compared to males, leaving a huge proportion of iron-deficient women undiagnosed and untreated.

“The fact that there is a difference in what is considered iron-deficient between men and women is insane,” Professor Nada Hamad, a Sydney haematologist and clinician researcher, said.

“Can you imagine how gaslit these women are when they are told that their iron level is normal, when, by definition, a man with the same results would have been diagnosed iron-deficient?” said obstetrician and gynaecologist Dr Talat Uppal, a leading international expert in heavy menstrual bleeding.

This is a modal window.

Following questions during this investigation, laboratory heads of pathology providers convened an emergency meeting, and those still upholding the “sexist practice” told this masthead that it would be overhauled.

Meanwhile, women with chronically depleted iron stores are offered no alternative to over-the-counter iron tablets, despite reporting brutal side effects, no improvements and pleading for iron infusions.

“I’ve got patients who have had untreated iron deficiency for years, then they wind up in emergency departments severely anaemic,” specialist haematologist Dr Lisa Clarke said.

“All because there are people in the healthcare system who truly don’t believe iron deficiency without anaemia in women is a problem.”

The women, doctors and experts are speaking not to blame individual healthcare professionals, but to expose entrenched, systemic gender bias in healthcare systems that can be traced back centuries, long before iron deficiency was believed to cause “hysteria” in women of the 16th century.

‘You have the blood count of a shark attack victim’

Abigail Rodwell had grown accustomed to being told by GPs not to worry about her fatigue, headaches and gastrointestinal symptoms.

“I can’t tell you how many times doctors have told me: you run a business, you’re studying your master’s degree, your doctorate, and you have two little children. You’re fine. Just rest,” Rodwell said.

Abigail Rodwell had been iron deficient for years but was offered no alternative to iron supplements with intolerable side effects.

“I’m pretty confident that men who work and have kids don’t hear that. They hear: how can we fix you?”

Rodwell got on with life until one evening in 2016.

“I was vomiting, I was struggling to breathe, and my whole body was cramping up,” she said.

Rodwell recalls screaming in pain as the paramedics carried her into the emergency department.

“The head nurse yelled at me, ‘I don’t know if you’re on drugs or something, but you will stop screaming’,” she said.

The mother of two was admitted for suspected influenza, but her blood test results showed her haemoglobin was 56 grams per litre (g/L). Normal haemoglobin levels typically range from 115 to 165 g/L. Rodwell was severely anaemic.

Iron is essential to make haemoglobin – a protein in red blood cells that binds to oxygen and transports it around the body. It is critical for tissue and organ function. Without treatment, iron-deficiency anaemia can cause life-threatening complications, including heart failure.

The attending gastroenterologist assumed she had cancer, Rodwell said.

“After an endoscopy, the gastroenterologist just said, ‘You don’t have cancer’ and told me to see my GP. That was it. Consultation over.”

At her GP, she was scolded for not taking iron supplements, Rodwell recalled.

Rodwell had tried taking various forms of supplements for years, but she couldn’t tolerate the gastrointestinal side effects.

Over-the-counter oral iron is the first-line treatment for iron deficiency and can be an effective option. But 30 to 70 per cent of people can’t tolerate the gastrointestinal side effects, including nausea, diarrhoea, constipation, and heartburn.

“[My GP] was so curt and rude, I had to stop myself from crying,” Rodwell said.

Between 2018 and 2020, her health slowly deteriorated. She had a constant headache, extreme fatigue, weakness, dizziness, pale skin, cold hands and feet, a slightly swollen tongue and loss of appetite.

“I was crunching ice all the time,” Rodwell said, unaware that craving ice is a symptom of iron deficiency.

Medical misogyny: a call for action

The Age and The Sydney Morning Herald last year launched an investigation into medical misogyny: ingrained, systemic sexism across Australia’s healthcare system, medical research and practise. 

More than 2000 women shared their experiences as part of our crowd-sourced investigative series, which prompted a national outpouring of grief and frustration as women described feeling gaslit, dismissed or being told their pain was “all in their heads”. 

We call on the federal government to boost Medicare funding for GP appointments that last more than 20 minutes to improve care for women and others with complex health conditions. 

The Albanese government and the Coalition have promised to pour $8.5 billion into Medicare to make GP visits more affordable and improve bulk billing rates, but longer 20-minute appointments will receive a smaller proportional funding increase. 

Doctors have warned that these policies could further disadvantage women by continuing to incentivise shorter consultations, which don’t give GPs enough time to address menopause, pelvic pain and other women’s health issues.

“I was just withering away, but I was still working. I would just take myself to the doctor, and the doctor would look at me and she wouldn’t be worried.”

In mid-2020, another blood test showed her haemoglobin was 53. Her GP sent her straight to hospital, where staff had prepared the resuscitation room.

“They said, ‘Do you know you could die at any second? You have the blood count of a car crash or shark victim’,” Rodwell recalled.

But she hadn’t had traumatic blood loss. It was her iron that had drained away.

Clarke was the haematologist assigned to Rodwell’s case. She said years of living with undiagnosed food intolerances had likely damaged Rodwell’s gastrointestinal tract, preventing her from absorbing iron from her food.

“Iron deficiency is so insidious,” Clarke said. “Abby had become used to functioning with low iron levels and subsequent anaemia until her haemoglobin finally dropped to critical levels.”

Clarke ordered a blood transfusion and two iron infusions.

“It was like I walked into sunshine from a dark room,” Rodwell said. “Everything, in hindsight, had been slower and more exhausting, both mentally and physically.”

The blood test that erases iron-deficient women

A contentious debate is playing out in clinics, laboratories and medical journals between clinicians and researchers, raising the alarm about untreated iron deficiency in women and their colleagues who don’t believe it’s an issue worth treating.

Editorial

Medical misogyny

Ignored and dismissed, women raise voices against medical misogyny

The Herald's View

The Herald's View

Editorial

“It’s incredibly frustrating because iron is critical for multiple functions beyond haemoglobin and red blood cells,” Clarke said.

But iron deficiency alone can impair the body’s cellular energy production.

“Iron is also required for the production of our feel-good messaging in our brains – serotonin and dopamine, which is how iron deficiency can be linked to depressed mood,” Clarke said.

There is a vagueness to some signs of iron deficiency (brain fog, fatigue) that medicine is not well-equipped to decipher.

Symptoms can also include hair loss, headaches, easy bruising, restless leg syndrome, a weakened immune system, and an eating or craving of dirt, paper, and ice.

A blood test for ferritin – a protein that stores iron, mainly in the liver – is the most sensitive indicator of a person’s iron stores.

National guidelines by the Royal College of Pathologists Australia were updated in 2021 to define iron deficiency as a ferritin level below 30 micrograms per litre (μg/L) for adults, eliminating a long-standing sex bias that meant women needed to have significantly lower ferritin levels than males to be diagnosed. Some pathology services, including Laverty, 4cyte and NSW Health Pathology use the same.

But other pathology providers, as well as the Australian Red Cross LifeBlood, still define iron deficiency as below 15μg/L for women. The variation means that for women whose ferritin level falls in the no man’s land between 15 and 30μg/L, getting diagnosed (and having a chance of treating it) can depend on which pathology service draws her blood. It’s a global problem.

Estimates suggest between 25 and 50 per cent of iron-deficient women are missed using 15 μg/L as a cut-off.

“I am seeing woman after woman who tell me that their iron results are always normal,” said Uppal, Australia’s appointee to the International Federation of Gynaecology and Obstetrics Committee on Menstrual Disorders and Related Health Impacts.

“I say, ‘No, your ferritin is 18. You have been iron-deficient for years’.

“Using lower, inconsistent cut-offs for women only perpetuates gender-based inequity and delays care for a condition that is both common and treatable,” Uppal said. “It is one of the reasons women with heavy menstrual bleeding can suffer and not get timely medical care.”

Setting reference ranges is not an exact science. But pathology sector insiders said the decision to set a lower floor for women comes down to the concern that too many women would be diagnosed as iron-deficient.

Up to 34 per cent of Australian women of reproductive age are iron-deficient – almost tenfold the proportion of iron-deficient men (3.5 per cent), according to an analysis of ABS data.

“It’s sexist. There’s no way around it,” said one pathology service employee not authorised to speak publicly.

Hamad said, “people will say, well, the World Health Organisation used 15 μg/L as the lower threshold. But WHO uses 15 [μg/L] for all adults and has to cater for services operating in some very limited-resource countries, so why are pathology services cherry-picking 15 for women and 30 for men?”

Chief medical officer for major pathology provider Douglass Hanly Moir, Adjunct Professor Annabelle Farnsworth told this masthead that after months of discussion, its laboratories will stop using 15μg/L as the cut-off for females, and instead use 30μg/L for all adults from September.

“It is completely the right thing to do,” Farnsworth said.

A spokesperson for SydPath, which also uses the lower floor for females, said its ferritin range was under review and its ranges would be updated to align with the RCPA’s.

Lifeblood’s medical director of pathology services Dr James Daly said the service was in the planning stages of changing the lower ferritin threshold for female donors to 30μg/L.

Research analysing other markers of iron deficiency suggests that even 30μg/L is too low.

The gold standard (but invasive) test that involves using a blue stain to visualise iron stores in bone marrow indicates 50 to 100 μg/L is the “sweet spot”, Hamad said.

‘Is this just in my head?’

It would take almost two years, countless doctors’ appointments, and the intervention of her father before Kate Burns was diagnosed with the condition for which she had all the hallmarks. Iron deficiency was just the precursor.

Burns was a 21-year-old with a deep trust in healthcare professionals when she started to believe that she might be a hypochondriac.

She had intense, almost constant headaches, waves of fatigue and extreme dizziness.

“My reflux was so severe I couldn’t lie flat. I had to prop up one end of my bed with chunks of wood,” Burns said.

The talented lacrosse player who had travelled solo overseas could no longer stay awake for the train ride to her university, walk upstairs without feeling dizzy and breathless, or keep up with her coursework. She was in almost constant pain and had lost an alarming amount of weight from her already slight frame.

But when her CT scan came back clear, her doctor intimated that she was exaggerating her symptoms, Burns recalled.

She told two GPs that the medication they had prescribed for reflux wasn’t working after several weeks of persisting.

The first doctor told her that she was overreacting, the second diagnosed her with anxiety and suggested she take antianxiety medication.

“I just burst into tears,” Burns said. “I went away questioning my sense of reality.”

When her blood test results showed her ferritin level was 6μg/L, indicating iron deficiency, her doctor told her to take iron tablets, but they exacerbated her reflux and nausea, and caused severe gut pain, Burns said.

“I’d been so unwell for a year now, and no one was listening to me,” Burns said.

“I was this shell of a human being … I would describe how drastically my life had changed to doctors, and it didn’t make any difference.”

Research analysing the use of iron supplements shows that by the time clinicians tell women to take them it’s often too late.

“We know it’s poorly absorbed, so we advise them to take it on an empty stomach and every day. That just increases gastrointestinal side effects, reduces compliance and sets it up for failure,” Clarke said.

Meanwhile, some iron supplements marketed as causing fewer side effects don’t contain enough absorbable iron to be effective, Hamad said.

“This annoys me because it’s a waste of money, generally for women, and a form of financial toxicity,” she said.

Kate Burns’ father, Mark, recalls her asking: “Dad, is this just in my head?”

“I would say, ‘What are you talking about, Kate? No, you’re unwell, look at you’,” he said.

“Seeing her world crumble … as a father, it tore me to pieces.”

He described coming home one evening to find his daughter deeply distraught and in pain.

“I said, ‘That’s it. I’m coming with you to the doctor’,” he said. “We saw a new GP and I insisted on some blood tests.”

Her ferritin was again 6μg/L. Further tests confirmed coeliac disease – a common cause of iron deficiency. Her body was not absorbing iron, calcium and other essential nutrients from her food.

Burns’ GP told her to stop eating gluten, take iron tablets, and directed her to a coeliac disease information website.

She discovered on her own that she needed an endoscopy to confirm the coeliac diagnosis and a bone density scan to assess the damage.

It took Burns two years to convince a doctor to prescribe an iron infusion – the most effective treatment for replenishing iron stores.

“They would just push the iron supplements” that only exacerbated her symptoms, she said.

Mark Burns can’t help but wonder whether Kate could have been spared the ongoing anguish of multiple autoimmune conditions triggered by her untreated coeliac disease if her doctors had intervened earlier.

“She has lost so much in her life,” he said.

From iron flood to a pregnant pause

Heavy menstrual bleeding (HMB) is considered the leading cause of iron deficiency. Defined as excessive menstrual blood loss which interferes with the woman’s physical, emotional, social and/or material quality of life, occurring alone or with other symptoms, it affects about one in four women of reproductive age.

Every month, these women lose a flood of blood (and iron) that seeps through their clothes or multiple forms of sanitary products, and pass clots larger than a 50-cent coin.

Studies suggest up to 60 per cent of women with HMB have severe iron deficiency, and half have not seen a doctor about it. No underlying cause (such as polyps, fibroids, adenomyosis, uterine or blood disorders) is found in about half of the cases investigated.

“These are staggering statistics,” said Uppal, who is also co-vice president of the Bleed Better initiative that helps co-ordinate the International Heavy Menstrual Bleeding Day (May 11). It aims to destigmatise HMB and raise awareness about available treatments.

“This is clearly a huge unmet clinical need and a public health issue,” Uppal said of the underdiagnosed condition.

Iron infusion is recognised as the most effective treatment for replenishing iron. But using iron infusion to treat pregnant women without anaemia is a contentious issue among obstetricians and gynaecologists. A lack of robust research underpins this.

Estimates suggest as many as 70 per cent of pregnant women in their third trimester are iron-deficient. Pregnant women need an additional 1 gram of iron throughout their pregnancy.

“You have some obstetricians who underplay the role of iron deficiency and are only interested once the woman becomes anaemic, and screening for iron deficiency is not uniform,” Clarke said.

The reluctance to use iron infusions is “a historic hangover”, Hamad said, “from decades ago, when there were problems with preparations, including allergic reactions, and the culture carried through to today”.

Dr Nisha Khot, president-elect of the Royal Australian and New Zealand College of Obstetricians and Gynaecologists, said the vast majority of obstetricians and gynaecologists recognise iron deficiency and will treat it.

“[But] it’s very hard to tease out whether they are caused by iron deficiency or if they are feeling this way because they are pregnant,” Khot said.

The scarcity of access to infusions and the common side effects of oral iron supplements (particularly for pregnant women) make managing iron deficiency very challenging, she said.

“It’s an issue of rationing,” Khot said. “We can’t provide everyone with an iron infusion as and when they need it.

“Within public hospitals, you can often say: ‘yes, this pregnant person needs an iron infusion’, but there just isn’t the capacity to give them [one] in a timely manner in all cases.”

Clarke, Hamad and Uppal were involved in the development of an unendorsed consensus statement to address the issue of untreated iron deficiency in pregnancy.

The statement recommends:

  • All pregnant women should be offered a blood test to check their iron and a full blood count in early pregnancy and again at 24 to 28 weeks.
  • Women with ferritin levels below 30μg/L should first be offered oral iron supplements.
  • Women in the second and third trimester who are low in iron, can’t tolerate oral iron or have tried without improving, should be offered an iron infusion.

Khot said most obstetricians would feel uncomfortable giving pregnant women an iron infusion after only four to six weeks of taking supplements.

Iron infusions come with a risk – though very rare – of anaphylactic reaction, she said, as well as skin staining (a brown iron mark if the cannula is incorrectly inserted).

“What we want is some clear guidance on how to diagnose and manage iron deficiency,” Khot said.

It all adds up

Iron infusions can also be prohibitively expensive. There is no Medicare subsidy. Patients pay $200 to $700 per treatment if they can’t get a referral to the limited public hospital infusion services.

At Dr Rebekah Hoffman’s general practice in Sydney, about 90 per cent of iron infusion patients are females, from teenagers through to pregnant and perimenopausal women.

“Most of our patients have heavy menstrual bleeding. They literally bleed out their iron every single month, so much so that their bodies are just not able to keep up,” said Hoffman, who is the NSW and ACT chair of the Royal Australian College of General Practitioners (RACGP).

Hoffman’s patients pay $200 to $300 out of pocket for an infusion every two to three years.

“That adds up,” she said. “There needs to be improved funding to cover iron infusions, whether that be for GPs, for hospitals, for outpatient care or for private hospitals.”

The RACGP has been lobbying the federal government to introduce a $200 rebate for iron infusions.

In response to questions from this masthead, Federal Health Minister Mark Butler said he had asked the Medical Services Advisory Committee to look at a Medicare item for iron infusions in general practice.

“The Albanese government is tackling sex and gender bias in the health system and improving health outcomes, particularly for women at greater risk of poor health,” Butler said in a statement.

“Women have asked government to take their healthcare seriously, and we have listened,” he said.

Here is the link:

https://www.theage.com.au/national/gaslit-dismissed-and-treated-as-hypochondriacs-the-gender-divide-in-iron-deficiency-20250729-p5mioa.html

It is amazing this is ever missed given the suffering it can cause and how easy it is to correct!

My advice, If a women looks even a little pale or lacks good exercise tolerance just check here Hb!

You can be a hero!

David.

Thursday, August 21, 2025

Only A Very Few Are Left From Those That Finally Got Rid Of Adolf Hitler And His Evil Henchman.

It is just over 80 years ago that the world saw the end of Hitler and the Nazis

Here is a brief reminder

Mein Kampf made depravity the highest form of morality: Hitler’s ‘Nazi bible’ a playbook for hate

Henry Ergas

16 August 2025

A picture-illustration showing Adolf Hitler in Munich in 1932 and his book, Mein Kampf. During WWII Hitler wore a simple uniform rather than the elaborate costume of a supreme commander, highlighting his affinity with the ‘grunts’ on the line. Picture: Heinrich Hoffmann/Archive Photos/Getty Images

When Adolf Hitler’s Mein Kampf (My Struggle) was published exact­ly 100 years ago, the reviews were scathing. The reader, proclaimed the Frankfurter Zeitung, could draw from the book one conclusion and one conclusion only: that Hitler was finished. The influential Neue Zurcher Zeitung was no kinder, lambasting “the sterile rumination of an agitator who is incapable of rational thought and has lost his grip on reality”.

As for Karl Kraus, the great Austrian essayist and critic, he famously dismissed it, quipping: “When I think of Hitler, nothing comes to mind.”

But while the book that would become known as “the Nazi bible” was hardly an immediate bestseller, it was far from being a dismal flop. By the end of 1925, nearly 10,000 copies had been sold, necessitating a second print run, and monthly sales seemed to be trending up. Even more consequentially, Mein Kampf, with its comprehensive elaboration of the Nazi world view, proved instrumental in consolidating Hitler’s until then tenuous position as the leader of the Nationalsozialistische Deutsche Arbeiterpartei  (National Socialist German Workers’ Party) or NSDAP. Both Hitler and Max Amann, who ran the Nazis’ publishing house, had good reason to be pleased.

After all, the initial circumstances of the book’s production were scarcely promising. When Hitler arrived at Landsberg prison in November 1923, following the failure of a farcically mismanaged putsch, he was assessed by the staff psychologist as “hysterical” and suicidal. However, having determined to end it all by embarking on a hunger strike, he sat down to write his valedictory statement – and with the full support of the prison’s director, a Nazi sympathiser who was happy to accommodate his every need, the project soon expanded, until the writing came to consume Hitler’s days.

Once Emil Georg, a director of the powerful Deutsche Bank and generous funder of the NSDAP, provided the aspiring writer with a top-of-the-line Remington typewriter, a writing table and all the stationery he required, Hitler’s new career as an author – the profession he proudly declared on his 1925 tax return – was well and truly under way.

The difficulty, however, was that Hitler wrote very much as he spoke. Page after page required substantial editing, if not complete revision. Some of it was undertaken by Rudolf Hess, who had a university degree, and Ernst Hanfstaengl, a German-American Harvard graduate. But many of the most difficult sections were eventually worked over by the unlikely duo of a music critic, Josef Stolzing-Cerny, and Bernhard Stempfle, a priest.

The greatest tensions arose in settling the title. Hitler, with his habitual grandiloquence, had called it Four and a Half Years of Battling Lies, Stupidity and Betrayal. Convinced that title would doom it to failure, Amann adamantly insisted on, and seems to have devised, a shorter alternative. Thus was Mein Kampf, the name that would go down in history, born.

Mein Kampf’s singular lack of focus proved tobe a strength.

Viewed superficially, the text, despite its editors’ best efforts, seems inchoate, veering across a bewildering range of grievances, pseudo-historical accounts and exhortations. Yet its singular lack of focus proved to be a strength. It meant there was something in it for each of the social groups the Nazis were attempting to mobilise, with every one of those groups finding the real or imagined harms that afflicted it covered in its pages. And whenever they were discussed, each group’s darkest nightmares were portrayed in striking, often lurid terms.

Hitler himself explained his approach in the book’s discussion of propaganda.

“Most people,” Hitler said, “are neither professors nor university graduates. They find abstract ideas hard to understand. As a result, any successful propaganda must limit itself to a very few points and to stereotypical formulations that appeal to instincts and feelings, making those abstract ideas vividly comprehensible.”

That is exactly what Mein Kampf set out to do – and it did so by hammering three basic themes: that the Germans were victims; that the culprit for the wrongs they had suffered were the Jews; and that only a fight to the death against “world Jewry” could bring Germany’s redemption and return it to the pre-eminence that was its birthright and historic destiny.

What gave the book its resonance was that each of those themes was well and truly in the air. Nowhere was that clearer than in respect of victimhood.

Thus, the end of World War I had not been viewed in Germany as a military defeat. Rather, the widespread perception, vigorously propagated by General Erich Ludendorff, was that had the German army, which retained undisputed mastery over its home soil, not been “sabotaged” by liberals, freemasons, social democrats and communists, it would have held out, forcing the Allies to a settlement.

Key themes in Mein Kampf was that the Germans were victims and the culprit for the wrongs they had suffered were the Jews.

The capitulation was, in other words, the result of a “stab in the back” that treacherously delivered the nation to the harsh, grotesquely unjust, treatment eventually meted out at Versailles by the war’s victors.

Closely associated with the resulting sense of unfairness, and of an undeserved defeat, was the smouldering resentment felt by returning soldiers.

World War I had ushered in the glorification of the rank and file, expressed in countries such as France, Britain and Australia by the erection of national memorials for the Unknown Soldier. Here was a figure that represented both the individual and the mass: sanctified by the nation, the Unknown Soldier also stood for the multitudes sent out to die and too quickly forgotten.

That was the case almost everywhere – but not in the newly established Weimar Republic. Unlike its counterparts, the republic erected no national monument, created no worthy memorial: the ghosts of the dead were left unburied.

Moreover, unable to deal with the trauma of the war, the republic accorded veterans no special status: even when their wounds made them entirely disabled, they were entitled only to the paltry benefits accorded to others suffering from similar levels of disability.

With the country’s new leaders abandoning those who had borne so many risks and so much pain on Germany’s behalf, an unbridgeable cleavage opened up between “those who had been there” – with all of their rage and frustration, fury and disillusionment – and those who had not. It is therefore no accident that both for innumerable forgotten soldiers and for the families who had lost their sons and fathers, Hitler, who had lived through the carnage, came to symbolise the unknown soldier of World War I.

Nor is it an accident that during World War II he always donned a simple uniform rather than the elaborate costume of a supreme commander, thereby highlighting his unshakeable affinity with the “grunts” on the line.

The last, but perhaps most broadly felt, source of the sense of victimhood was the devastation wreaked by the “great inflation”.

The immediate effect of the price hikes, which began in 1921, accelerated in late 1922 and became a hyperinflation (that is, one involving monthly price increases of more than 50 per cent) in 1923 was to obliterate the savings of skilled workers, pensioners and the middle class. No less important, however, it also shattered those groups’ social standing which, in a society still geared to honour and respectability, relied on the ability to conspicuously maintain a dignified lifestyle appropriate for one’s status. Instead, for the first time in their lives, previously comfortable professionals, foremen and highly trained workers were reduced to a struggle of all against all, as they vainly attempted to sell once prized, often hard-earned assets that had suddenly – and mysteriously – become utterly valueless.

And as well as leaving a legacy of trauma, that experience created an enduring sense of unpredictability, casting the new republic as incapable of maintaining intact even the elementary foundations of daily life.

Stefan Zweig was therefore not exaggerating when he wrote, in his The World of Yesterday, that “nothing ever embittered the German people so much, nothing made them so furious with hate as the inflation. For the war, murderous as it was, had yet yielded hours of jubilation, with ringing of bells and fanfares of victory. And, being an incurably militaristic nation, Germany felt lifted in her pride by her temporary victories. But the inflation served only to make it feel soiled, cheated, and humiliated. A whole, scarred, generation could never forget or forgive.”

But where there are victims there must be victimisers – and Hitler delivered those too. Towering among them were the Jews.

Mein Kampf’s obsession with Jews is readily demonstrated: including cognate terms, such as Jewry, the 466 references to Jews in the book outnumber those to every other substantive term, including race (mentioned 323 times), Germany (306), war (305) and Marxism, which gets a paltry 194 – still ahead of national socialism and national socialists which, taken together, are referenced only 65 times.

It is certainly true that there is, in those obsessive references, virtually nothing original. Hitler’s tir­ades largely reassemble the anti-Semitic tropes that had emerged in the late 19th century and that were widely disseminated in a notorious forgery, The Protocols of the Elders of Zion.

But Hitler’s formulation, while substantively irrational, was arguably more logical than most in the way it combined and superimposed elements from conventional anti-Semitism, pseudo-biology and social Darwinism.

glory and greatness began to emerge. Hitler with Nazi officials in Munich in the summer of 1939, just before the start of WWII.

Thus, relying on a loose biological metaphor, it defined Jews as a parasite – but as one that had deliberate agency and that consciously (and collectively) sought to infect its victims, notably the “purer”, more advanced “races”.

Second, it asserted that the resulting infection was not only fatal to its victims but ultimately to their entire “race”.

Third, it projected on to that account the image of a Darwinian struggle that had been fought across recorded history’s entire course, between Jews on the one hand and the superior races on the other: a struggle that could end only with the extinction of the Jews or their adversaries.

And finally, it argued that, unless anti-Semites learnt to display the same degree of ruthlessness, the same insistence on ethnic loyalty, the same stealth and the same forms of manipulation of media and the public sphere, the Jews stood every chance of triumphing because they entirely lacked ethical standards, were exceptionally cunning, ambitious, aggressive and vindictive and – last but not least – had a natural bond to each other, combined with a murderous hatred of others.

The resulting portrayal of Jews was as terrifying as it was bizarre. Jews, it seemed, were chameleons, who were both subhuman yet extraordinarily capable, both fanatical Bolsheviks and natural capitalists, both physically repulsive yet immensely able to seduce and “infect” innocent Aryan maidens.

Moreover, they could shift effortlessly and surreptitiously from any one of those myriad shapes into any another, choosing whatever form was most likely to succeed in destroying their opponent.

As the great German philosopher Ernst Cassirer later recalled, he and his other Jewish friends found those claims “so absurd, so ridiculous, and so crazy, that we had trouble taking them seriously”. But others did not have any difficulty in doing so.

Many forces were at work. Some resulted from the war years. For example, the terrible food shortages caused by the British blockade (which was lifted only two years after the war ended) had resulted in spiralling prices for basics on the black market – with the finger being readily, although entirely incorrectly, pointed at alleged hoarding by Jews.

And more indirectly, but no less potently, the horrific second wave of the 1919 influenza pandemic, in which 400,000 Germans died, had given enormous prominence to notions of infection and contagion. As careful statistical studies subsequently showed, that prominence had enduring effects, as the Nazis secured significantly greater electoral support in the worst affected areas than in those where the death toll was lower.

But by far the greatest factor was the profound disruption of the post-war years, when everything Germans had taken as solid melted into thin air, leaving a pervasive feeling of bewilderment.

For all of its myriad flaws, the Kaiserreich, as the German Empire was known, had exuded a stability that made the future predictable. Now, with one seemingly incomprehensible event piling up on top of another, the desperate search to make sense of the world triggered an equally desperate search for someone to blame.

That was precisely what Hitler’s vast Jewish conspiracy offered. Mein Kampf, Heinrich Himmler pithily noted, was “a book that explains everything”. If it was so effective, Hannah Arendt later reflected, it was because its playing on tropes and stereotypes that were relatively familiar could, at least superficially, “fulfil this longing for a completely consistent, comprehensible, and predictable world without seriously conflicting with common sense”. All of a sudden, things fell into place – with consequences for Europe’s Jews that would forever sully Germany’s name.

If those horrendous conse­quences eventuated, it was because Mein Kampf did not only identify an alleged disease; it also set out a path to national redemption. In that respect, too, its main points were entirely unoriginal.

However, what was relatively new, and especially important, was the unadulterated celebration of death and violence in which they were couched.

Whether Hitler called for Jews to be massacred is a matter of interpretation. What is beyond any doubt is that he came as close to it as one possibly could. The Jews, he claimed, would “accentuate the struggle to the point of the hated adversary’s bloody extermination”. As that happened, it would be absolutely impossible to defeat them “without spilling their blood”. And when it came to that, their opponents, locked “in a titanic struggle”, would have to “send to Lucifer” – that is, to hell – “those who had mounted an assault on the skies”: that is, the Jews.

There would be, in the process, countless victims; but the Aryans who perished would be martyrs, “acting in accordance with the will of the Almighty Creator”, and like Hitler himself “fighting for the work of the Lord”.

As with so much of Mein Kampf, the sheer violence of those calls, and of the text more generally, fell on fertile ground, again especially among veterans.

If those veterans had one thing in common it was the experience of “total war”, characterised by the ever-growing porousness of the boundaries between soldiers and civilians both as combatants and as targets of destruction.

Once they got to the front, it did not take long for ordinary soldiers to discard the fantasies of splendid bayonet charges across fields of flowers. Instead, burrowed underground in trenches filled with slime and excrement, rats and rotting body parts, what many learnt was that life was war, and war was life.

And at least for some, the sacrifice and devotion of their comrades also taught that violence brought out the best qualities in man.

Rendering that habituation to violence even more extreme was the experience of the 5 per cent or so of German soldiers who volunteered for Freikorps (Free Corps) units that fought, from 1918 to 1923, against the wave of revolutionary movements throughout central and eastern Europe.

Particularly in the Baltic states, those struggles were brutally uncompromising, with mass executions not only of adversaries but also of entire villages of helpless Jews. It was in those struggles that many ingredients of Nazism were forged – its symbols, like the death’s head and the swastika; its core staff, who later largely comprised the leading personnel first of the Nazi’s paramilitary units and then of the SS; and the unbridled anti-Semitic savagery of its killing squads. To all those who lived through those struggles, Mein Kampf seemed to perfectly capture their world view.

But Mein Kampf’s promise of redemption was crucial, too. Yes, Germany experienced the aftermath of World War I as an unmitigated disaster. Yet, from the midst of despair, a new notion of German glory and greatness began to emerge. When the war finally ended, the survivors could not but feel an urge to endow it with meaning – with the hope that the countless deaths would be redeemed by creating a better future, not only for themselves but also for the nation, a future shorn of the causes of everything that had gone wrong.

And no one, in the chaos and misery of post-World War I Germany, painted the path to that national salvation as starkly, and as effectively, as Hitler.

Death and destruction follow delirium as surely as dust and ashes follow fire. Two long decades, punctuated by Hitler’s accession to power in 1933, separated, almost precisely, the publication of Mein Kampf from the “Zero Hour”, as it became widely known, on May 7, 1945, when Germany, reduced to rubble, surrendered and officially ceased to exist. The vision – or hallucinations – Hitler had produced in Landsberg’s jail ensured that the 20th century’s fields of glory would be sown with the corpses of innocent victims and the distorted fragments of shattered ideals.

Between those dates, the book’s fortunes closely tracked those of its author. After the crash of 1929, and the onset of the Depression, sales boomed; and once the Nazi regime was in place it became ubiquitous. A second volume had appeared in December 1926; it was added to the 400 pages of the first in 1930.

To cope with the length, the combined book was printed on extremely fine paper, exactly like a bible. Soon after that, an ever-wider range of formats – going from cheap paperback versions to extremely luxurious versions bound in leather – was offered to readers.

The regime recommended that municipalities give a good quality copy to newly married couples as they stepped out of the wedding ceremony; estimates vary but it seems two million couples benefited (if that is the right word). The book also became the standard prize in schools, workplaces and party organisations, bestowed on recipients with all the pomp the Fuhrer’s great work demanded. Altogether, by the “Zero Hour”, 12.5 million copies had found their way into the hands of potential readers – yielding Hitler copyright payments, partly deposited in a Swiss bank account, that made him an extremely wealthy man.

How many Germans actually read it is hard to say; the answers given to immediate post-war surveys were understandably evasive. What seems likely, however, is that its influence came less from the scrupulous consumption of the “Nazi bible” than from short excerpts, read out at meetings and over the radio or printed near the mastheads of major papers, as well as from the million or so copies of “reader’s digest”-like variants sold during the Reich’s golden years.

In the chaos and misery of post-WWI Germany, no one painted the path to that national salvation as starkly, and as effectively, as Hitler

But its greatest impact was almost certainly indirect. Regardless of what ordinary Germans may or may not have done, abundant evidence shows it was carefully studied and frequently consulted by the Nazi leadership. The regime’s core principle, the so-called Fuhrerprinzip, specified that “what the Fuhrer says is law”: but what the Fuhrer had actually said, and even more so, what he wanted, was almost always hopelessly unclear – yet entire careers depended on guessing it accurately.

As a result, the everyday life of the Nazi hierarchy’s upper echelons was consumed in a competi­tion to “work towards the Fuhrer”, as Hitler’s great biographer, Ian Kershaw, called it: that is, in trying to anticipate the Fuhrer’s will and show that no one could be more ruthless or determined in putting it into effect. It was in that process that Mein Kampf was absolutely fundamental, invariably referred to and systematically used.

And it was through that process that Hitler’s words made depravity the highest form of morality, atrocity the surest sign of heroism, and genocide the key to redemption.

Outside Germany, very few grasped that those horrors would unfold. Winston Churchill, Franklin Delano Roosevelt, Charles de Gaulle and David Ben-Gurion were among those few, carefully annotating early versions and gasping at the book’s implications.

But their warnings were ignored because Mein Kampf was plainly the work of a madman. As the British Labour Party’s leading intellectual, Harold Laski, said, when he was asked why he dismissed it, rational men and women “could not bring themselves to contemplate such a world”, much less believe that “any child of the twentieth century” would regard it as a realistic possibility.

But the Nazi art of politics, as Joseph Goebbels concisely defined it, consisted precisely in making the impossible possible and the absolutely inconceivable a practical reality. That art did not disappear with Nazism’s demise, nor did the murderous anti-Semitism whose seeds Hitler sowed a century ago.

Here is the link:

https://www.theaustralian.com.au/inquirer/mein-kampf-made-depravity-the-highest-form-of-morality-hitlers-nazi-bible-a-playbook-for-hate/news-story/47043792d33d2366dd7ad36e835c50e5

None should forget just how evil his and his followers were and how wonderful is that he and the Nazis were defeated after 5 terrible years. My father told me that for the first few years of WWII it was no sure thing that he would be defeated and that until the USA and the Russians got organized and involved it was a close run thing! Something as evil could return so we need to stay alert to such evil ideologies and risks.

David.

Wednesday, August 20, 2025

It Really Is Not Good Enough That Private Health insurance Costs Are So Complicated!

This appeared earlier today!

Medicare levy surcharge payers almost quadruple in six years

Anthony Keane

17 August, 2025

More Australians are paying extra tax through the Medicare levy surcharge, potentially wasting their money.

The latest Australian Taxation Office figures show a sharp rise in taxpayers hit by the surcharge, which is between 1 and 1.5 per cent extra tax on their income above a certain threshold if they do not have private hospital insurance.

It can be cheaper for singles and families to buy private hospital cover, although experts say the lowest-cost policies offer very little value.

Rising wages have meant the Medicare levy surcharge now kicks in at a level below the nation’s average full-time wage of $102,632, and the new ATO data shows 768,537 individuals paid a surcharge averaging $1318 in the 2022-23 financial year.

That was an annual increase of 25 per cent, while the number of payers has almost quadrupled in six years, from 196,807 in 2017.

For 2025-26, a Medicare levy of 1 per cent is payable by singles earning above $101,000 a year and couples earning above $202,000, and rises to 1.5 per cent for individuals and couples on more than $158,000 and $316,000, respectively. Families with children have slightly higher thresholds.

Hospital cover is needed to avoid the Medicare levy surcharge. Picture: iStock

Tribeca Financial chief executive Ryan Watson said Australians’ average incomes had increased dramatically over the past six years.

“This puts a lot of people above the surcharge threshold, thus a lot more people are duty-bound to pay it,” he said.

Mr Watson said people should do some research to understand if they were paying the surcharge.

“We suggest all of our clients have private health insurance for a number of reasons, not least to avoid paying another government levy or surcharge.”

H&R Block director of tax communications Mark Chapman said he suspected more people were choosing to pay the surcharge because “the cost of health insurance is so expensive”.

“The issue with hospital cover is although it might be sufficient to avoid the Medicare levy surcharge, it might not be sufficient to provide a level of cover that you actually expect,” he said.

Research shows basic hospital cover – the minimum to avoid the tax – starts at about $100 a month, but for higher-level “silver” hospital cover, average monthly costs are about $300-$400 for families and $160 for singles.

Mr Chapman said health fund members might be horrified to discover the long list of exclusions on basic hospital policies, and some “are not worth the paper it’s written on”.

Government figures show about 12.3 million Australians have private hospital cover.

Compare the Market economic director David Koch said people could be stung by the Medicare levy surcharge without knowing.

“Even when your salary does go up and you’re bumped over the threshold, your employer probably isn’t going to let you know … for a lot of people, the first time they’ll hear about the Medicare levy surcharge is when they start their tax return.”

Compare the Market makes money by referring to customers to partnered health funds.

“You pay the MLS every day during a financial year that you don’t hold private hospital cover,” Mr Koch said.

“That means you can’t just wait until tax time or the very last minute to take out cover to avoid the tax – if you want to avoid MLS entirely, you must cover for each day of the financial year.”

To avoid the surcharge, for singles, appropriate hospital cover must have an excess of $750 or less, while for couples the excess must be $1500 or less, comparison website iSelect’s spokeswoman Sophie Ryan said. Like Compare the Market, iSelect is paid by the private health insurance providers it refers customers to.

“In some cases, Aussies mistakenly believe extras-only policies exempt them from the MLS,” she said. “Many may be caught out because they assume extras-only cover is enough to avoid the surcharge, which it’s not.”

Analysis by iSelect found the average monthly premium for a basic hospital-only policy was $98.36. “There may be a small cost difference between paying the additional tax or taking out a level of hospital cover which may provide significant benefit should you experience a health issue in the future,” Ms Ryan said.

Here is the link:

https://www.theaustralian.com.au/wealth/personal-finance/medicare-levy-surcharge-payers-almost-quadruple-in-six-years/news-story/295b2b5d543851d02ce6a00305edbf1f

To me this is a decision we all have to make (how much etc.) and then keep and eye on to make sure it is not going up unnoticed, and we are getting value for money! What you need to  pay varies throughout life and your coverage needs to be adjusted to suit. Well worth seeking advice if unsure...

David. 

 

Tuesday, August 19, 2025

The Medicare Surcharge Is Really Getting To Be A Significant Expense!

This appeared earlier today.

Medicare levy surcharge payers almost quadruple in six years

Anthony Keane

17 August, 2025

More Australians are paying extra tax through the Medicare levy surcharge, potentially wasting their money.

The latest Australian Taxation Office figures show a sharp rise in taxpayers hit by the surcharge, which is between 1 and 1.5 per cent extra tax on their income above a certain threshold if they do not have private hospital insurance.

It can be cheaper for singles and families to buy private hospital cover, although experts say the lowest-cost policies offer very little value.

Rising wages have meant the Medicare levy surcharge now kicks in at a level below the nation’s average full-time wage of $102,632, and the new ATO data shows 768,537 individuals paid a surcharge averaging $1318 in the 2022-23 financial year.

That was an annual increase of 25 per cent, while the number of payers has almost quadrupled in six years, from 196,807 in 2017.

For 2025-26, a Medicare levy of 1 per cent is payable by singles earning above $101,000 a year and couples earning above $202,000, and rises to 1.5 per cent for individuals and couples on more than $158,000 and $316,000, respectively. Families with children have slightly higher thresholds.

Hospital cover is needed to avoid the Medicare levy surcharge. 

Tribeca Financial chief executive Ryan Watson said Australians’ average incomes had increased dramatically over the past six years.

“This puts a lot of people above the surcharge threshold, thus a lot more people are duty-bound to pay it,” he said.

Mr Watson said people should do some research to understand if they were paying the surcharge.

“We suggest all of our clients have private health insurance for a number of reasons, not least to avoid paying another government levy or surcharge.”

H&R Block director of tax communications Mark Chapman said he suspected more people were choosing to pay the surcharge because “the cost of health insurance is so expensive”.

“The issue with hospital cover is although it might be sufficient to avoid the Medicare levy surcharge, it might not be sufficient to provide a level of cover that you actually expect,” he said.

Research shows basic hospital cover – the minimum to avoid the tax – starts at about $100 a month, but for higher-level “silver” hospital cover, average monthly costs are about $300-$400 for families and $160 for singles.

Mr Chapman said health fund members might be horrified to discover the long list of exclusions on basic hospital policies, and some “are not worth the paper it’s written on”.

Government figures show about 12.3 million Australians have private hospital cover.

Compare the Market economic director David Koch said people could be stung by the Medicare levy surcharge without knowing.

“Even when your salary does go up and you’re bumped over the threshold, your employer probably isn’t going to let you know … for a lot of people, the first time they’ll hear about the Medicare levy surcharge is when they start their tax return.”

Compare the Market makes money by referring to customers to partnered health funds.

“You pay the MLS every day during a financial year that you don’t hold private hospital cover,” Mr Koch said.

“That means you can’t just wait until tax time or the very last minute to take out cover to avoid the tax – if you want to avoid MLS entirely, you must buy cover for each day of the financial year.”

To avoid the surcharge, for singles, appropriate hospital cover must have an excess of $750 or less, while for couples the excess must be $1500 or less, comparison website iSelect’s spokeswoman Sophie Ryan said. Like Compare the Market, iSelect is paid by the private health insurance providers it refers customers to.

“In some cases, Aussies mistakenly believe extras-only policies exempt them from the MLS,” she said. “Many may be caught out because they assume extras-only cover is enough to avoid the surcharge, which it’s not.”

Analysis by iSelect found the average monthly premium for a basic hospital-only policy was $98.36. “There may be a small cost difference between paying the additional tax or taking out a level of hospital cover which may provide significant benefit should you experience a health issue in the future,” Ms Ryan said.

Here is the link:

 https://www.theaustralian.com.au/wealth/personal-finance/medicare-levy-surcharge-payers-almost-quadruple-in-six-years/news-story/295b2b5d543851d02ce6a00305edbf1f 

Whether to buy health insurance is an individual decision based on your economic circumstances and needs and really has to be reviewed every year or two if you are not paying the lowest level of private insurance to ensure what you are doing is economically sensible!

Probably worth checking with your accountant to validate what you are doing as it is quite complex...

David. 

Sunday, August 17, 2025

Donald Trump Is Proving To Be A Very Untrustworthy Individual IMVHO!

This appeared earlier today!

Donald Trump

Trump reportedly to back ceding of Ukrainian territory to Russia as part of peace deal

Details of post-summit call were leaked in which US president supports plan for Kyiv to give up Donbas region

Edward Helmore and Pjotr Sauer

Sun 17 Aug 2025 04.25 AEST

Donald Trump will back a plan to cede unoccupied Ukrainian territory to Russia to secure an end to the war between the two countries, it was reported on Saturday, after details of his post-summit call with European leaders leaked out.

Trump told European leaders that he believed a peace deal could be negotiated if the Ukrainian president, Volodymyr Zelenskyy, agreed to give up the Donbas region, which Russian invaders have not been able to seize in over three years of fighting, the New York Times reported, citing to two senior European officials.

Two sources with direct knowledge of the talks in Alaska told the Guardian that Putin demanded Ukraine withdraw from Donbas, which is made up of the Donestk and Luhansk regions, as a condition for ending the war, but offered Trump a freeze along the remaining frontline.

Although Luhansk is almost entirely under Russian control, Ukraine still holds key parts of Donetsk, including the cities of Kramatorsk and Sloviansk and heavily fortified positions whose defence has cost tens of thousands of lives.

Putin told Trump that in exchange for Donetsk and Luhansk, he would halt further advances and freeze the frontline in the southern Ukrainian region of Kherson and Zaporizhzhia, where Russian forces occupy significant areas.

Trump’s support for ceding Ukraine’s Donbas region, which is rich in mineral resources, including coal and iron ore, to Russia comes as he voiced support for moving straight to a peace deal and not via a ceasefire, which, Trump said in a social media post on Saturday, “often times do not hold up.”

US support for ceding the Donbas to Russia represents a breach with Ukraine and European allies that oppose such a deal.

As part of a deal, the US is ready to be part of security guarantees for Ukraine, the German chancellor, Friedrich Merz, said on Saturday. Trump has threatened economic penalties on countries that buy Russian oil if Moscow refuses a deal and flew US bombers over the Russian leader as he arrived in Alaska.

But Ukrainian and European leaders fear that a straight-to-peace deal, skipping over a preliminary ceasefire, gives Moscow an upper hand in talks. Zelensky is expected in Washington on Monday to meet with Trump. Europeans were invited to join the Ukrainian leader at the White House, officials told the New York Times.

Trump claimed on Saturday in his post that “it was determined by all” that it was better to go directly to negotiated a peace agreement, though European leaders indicated this was not their view.

A joint statement issued by European leaders said they were “ready to work with US President Trump and Ukrainian President Zelenskyy towards a trilateral summit with European support” but “it will be up to Ukraine to make decisions on its territory. International borders must not be changed by force.”

The statement was signed by the European Commission president, Ursula von der Leyen; the French president, Emmanuel Macron; the Italian prime minister, Giorgia Meloni; the German chancellor, Friedrich Merz; the British prime minister, Keir Starmer; the Finnish president, Alexander Stubb; the Polish prime minister, Donald Tusk; and the European Council president, António Costa.

They said they “welcomed President Trump’s efforts to stop the killing in Ukraine, end Russia’s war of aggression, and achieve just and lasting peace”.

Zelensky said in a statement after his conversations with Trump and the European leaders: “The positions are clear. A real peace must be achieved, one that will be lasting, not just another pause between Russian invasions. Killings must stop as soon as possible, the fire must cease both on the battlefield and in the sky, as well as against our port infrastructure. All Ukrainian prisoners of war and civilians must be released, and the children abducted by Russia must be returned.”

European leaders, including Macron, Merz and Starmer, are set to discuss the issues with Zelenskyy on Sunday via video call ahead of his meeting with Trump, the French president’s office said in a statement.

Here is the link:

https://www.theguardian.com/us-news/2025/aug/16/ukraine-russia-peace-deal-donbas-region

Heavens above! Just when does "The Donald" think it is OK to give another person’s country away to make nice to Mr Putin.

You can’t trust “The Donald” as far as you can throw him, which is not very far!

Reckon he would give away Tassie if Vlad asked nicely?

Trump is an unprincipled jerk IMVHO!

What do you think?

David.

AusHealthIT Poll Number 807 – Results – 17 August 2025.

Here are the results of the recent poll.

Are You Expecting The Upcoming National Economic Summit To Produce Any Useful Outcomes?

Yes                                                                       9 (47%)

No                                                                      10 (53%)

I Have No Idea                                                    0 (0%)

Total No. Of Votes: 19

A very nearly tied vote – with readers not sure who won, but a slight majority seeing a bit of  waste of time coming! It starts Monday!

Any insights on the poll are welcome, as a comment, as usual!

Poor voter turnout – question must have been useless. 

0 of 19 who answered the poll admitted to not being sure about the answer to the question!

Again, many, many thanks to all those who voted! 

David.

Friday, August 15, 2025

This Really Is An Astonishing Australian Success Story! And I Was There When It Started!

This appeared last week:

How ResMed’s Mick Farrell turned a $7b company into a $62b giant

Family business successions are often a disaster. At ResMed, the global sleep device manufacturer, it has proven to be a winning formula.

Michael Smith Health editor

Aug 8, 2025 – 8.02am

When Mick Farrell’s dad, Peter, first invited him to come and work at ResMed, which makes breathing devices for sleep apnoea, he scoffed at the idea. Farrell, an ambitious 26-year-old consultant, was being courted by two US multi-billion dollar companies – med-tech giant Boston Scientific and biotech Genzyme – and he wasn’t interested in working for his father’s start-up, which was worth about $50 million at the time.

“He asked me to come out to San Diego and interview with his company,” recalls Farrell. “I said, ‘No offence, Dad, but your little $50 million start-up … ResMed is it? ... in the seaside hamlet of San Diego?’”

Farrell’s youthful arrogance was met with an expletive-ridden tirade from his father down the phone line. He still won’t repeat it to this day. “I am not going to quote the exact words he said back then, but it was along the lines of: ‘Listen, you arrogant little so-and-so. This is a huge opportunity for you … expletive … expletive.’ ”

But Farrell could be as stubborn as his father, so it was up to his girlfriend, Lisette, to convince him to get on the plane to San Diego and spend Thanksgiving with his dad, and while there meet with a ResMed interviewing committee. His dad wasn’t on the panel.

On the flight over, Farrell was crunching the numbers on ResMed and its potential. “I was sitting on the plane with Lisette and I said to her: ‘This company, this market, this opportunity is huge! My crazy dad is right!’”

Twenty-five years later, and Farrell, now 53, is ResMed’s chief executive. He married Lisette and they have two kids. And as for that little start-up? Well, it’s now a global company worth $63 billion, with customers in 140 countries.

Farrell is telling the ResMed origin story on a recent return visit from San Diego, where he’s lived for the past three decades, to Australia. He is speaking to me from his mum’s house in the northern beachside Sydney suburb of Manly, where he slept the night before on a fold-out bed, along with his portable ResMed CPAP device and mask. The device and mask are used to treat sleep apnoea, which is estimated to afflict almost 1 billion people worldwide.

“In the morning I wake up fired and ready to go,” says Farrell, who’s never one to miss a marketing opportunity. He also refers to some of the company’s 10,000 employees as “ResMedians”.

Farrell, who’s stocky, with a thinning hairline, talks in rapid-fire sentences, and has largely retained his Australian accent. He was born in Seattle but grew up in Sydney, before returning to live in the US.

He’s in Australia this month to see family and meet with investors after delivering a stellar full-year result for the medical device manufacturer. ResMed’s earnings were up almost 40 per cent. He has also been in Sydney to catch some footy, with ResMed a sponsor of the recent British and Irish Lions tour against the Wallabies. “I love Sydney even when it is rainy and cold. At the rugby, the rain was coming in sideways!”

Farrell, whose early career included a stint working for BHP designing water cooling systems for steel production, will have been ResMed’s chief executive for 17 years at the end of this decade. It’s a long time, according to corporate governance experts, but Farrell brushes it off.

“Despite my beautiful hairline I am only 53,” he laughs. “I have a good innings [ahead] to finish this 2030 strategy. I am looking at long-term [succession] plans and working with my fellow board of directors to think about that,” he says. “It is a big question always at public companies.”

“I fell in love with that overlap of science and altruism and the profit motive. I have never looked back.”

— Mick Farrell

The market is happy for the Farrell-lineage to continue for some time yet.

“He’s not that old. We would be pleased to see him stay for at least another five years,” says Andrew Dale, a portfolio manager at ECP Asset Management.

Bell Direct analyst Grady Wulff agrees. “I don’t think he is going anywhere,” says “He’s the person you want at the helm really. He is very hands-on in every division. The ResMed brand is in his DNA. ”


ResMed was started in 1989 by Peter Farrell, a chemical and bioengineer turned entrepreneur. He saw the potential of a new technology then under development by Colin Sullivan at the University of Sydney, which ResMed would acquire and commercialise, to treat sleep-related breathing disorders. He moved the headquarters to California in 1994 after the company outgrew Sydney, but at one stage considered relocating to Texas because the state was “too Democratic” and high-taxing. He never followed through on that threat.

Farrell junior would follow in his father’s footsteps. A first-class honours student at school in Sydney, he too studied to be a chemical engineer at the prestigious Massachusetts Institute of Technology, where he had gained a scholarship, before later earning an MBA.

“I fell in love with that overlap of science and altruism and the profit motive. I have never looked back,” says Farrell.

After working for BHP, and a stint as a consultant, Farrell rang his father for career advice, which is when the job offer was made to come into what was then a family business. It was 2000, and despite the tense phone call, Farrell junior eventually joined ResMed, initially in business development and marketing roles, before eventually climbing the ladder to become head of the Americas division.

In 2013, he succeeded his father as the company’s chief executive and is credited with continuing to build the company’s market share and develop the technology in breathing machines, masks and other sleep devices. He has cemented ResMed’s place as one of Australia’s corporate healthcare success stories alongside CSL and Cochlear.

“When I took over ResMed in 2013, it was already a strong company,” says Farrell, but adds that there are distinctions between him and his father in how they operate. “There are very big differences. He was a founder and entrepreneur. I am chairman and chief executive.”

He knows the succession to become ResMed’s chief executive could be painted as blatant nepotism – he is the youngest of three children – but denies this was the case. “In the early days I had to work harder and work longer. I learnt a lot from my dad about what to do in business and ambition.

“He was big about getting as educated as you can, work as hard as you can and take your god-given talents to the world and double them. He saw some talent in me, and he didn’t want it to be wasted.

“From my mother, who was a nurse, I learnt how to make sure that while you are doing all that, you take care of people, your friends, your family, yourself. That balance of intellectual ambition and care and love.”

Resmed founder Peter Farrell saw the potential of the technology under development at the University of Sydney to treat sleep-related breathing disorders, which he acquired and commercialised. Peter Rae

Peter Farrell, who stepped down as ResMed’s chairman in 2023, declined to comment on his son. A company spokeswoman said he no longer does media interviews and is enjoying his time on the golf course.

For a man who makes his living out of those who suffer from insomnia and poor sleep, there’s not much that keeps Farrell junior awake at night. And understandably, because right now he is riding high.

ResMed’s dual-listed shares hit a record $45 on the Australian Securities Exchange last week. During Farrell junior’s tenure, ResMed’s market value has grown from $7 billion to $62 billion.

“ResMed’s market cap growth over his tenure says it all,” says Anna Milne, ​a deputy portfolio manager at Wilson Asset Management. “He has transformed the company in a number of respects. ResMed has shifted from being a primarily hardware-focused CPAP device manufacturer, to a sleep and respiratory care global leader. His focus on technology and data has been ahead of its time.”

If there is something that worries Farrell, it’s technology and cybersecurity threats for ResMed, which has 23 billion nights’ worth of patient medical data in the cloud.

“In California, people fail all the time and get back up again, and people say you are learning.”

— Mick Farrell

He shares an anecdote about a recent meeting he had with technology leader Jensen Huang, Nvidia’s chief executive, who is personally worth $US150 billion from the success of his semiconductor company.

“I was at this small event with 20 CEOs and Jensen arrives with his cool leather jacket, and he is worth a couple of billion dollars more just that morning. You know me, I’m talkative, so I made the mistake of being the one in the group to ask him a question.”

Farrell’s question was about how to engage your board in strategy, but Huang said the premise of his question was wrong. He said it was impossible to have a five-year fixed strategy in a world where artificial intelligence was changing things daily.

What does the future hold for ResMed?

“I realised ResMed isn’t going to be the world leader in machine learning and AI, but we will be the world leader in applying Generative AI in the field of sleep health.”

Technology is where Farrell is focused for ResMed’s future. He’s less concerned about government regulation or the Trump administration’s whipsawing on global tariffs, which has caused headaches for so many multinationals.

He says the regulatory and political upheaval occurring under the Trump presidency is not a problem for ResMed, which he argues is tariff-proof. He says ResMed, which manufactures sleep devices and masks in Australia and Singapore, is protected under an international agreement called the Nairobi Protocol, which guarantees duty-free treatment for products that help people with disabilities.

Still, Trump administration observers would argue that it is remaking the world order in ways that were once unthinkable.

Farrell, a Republican, cites Ronald Reagan as the US president he most admires. He has not met Trump yet, but expects to in his new role as chairman of the Advanced Medical Technology Association, a global trade association.

“I haven’t met Donald himself, but I think it is quite possible over the two years as chairman, I will be shaking hands with the head of the ministries of health in Europe and maybe the president as well.”

Farrell’s sanguine approach to government is a marked difference to his father, who was very outspoken in criticising governments, both in Australia and the United States, over high taxes, excessive regulation and overspending.

It’s not to say that Farrell doesn’t have views. He’s just not as outspoken as his old man. For example, he believes that in Australia, more could be done by politicians to support interactions between industry and universities.

He says ResMed does its best to capitalise on Australia’s innovative talent. “We have our advanced engineering next to our advanced manufacturing here, and we can teach and learn from [our offices in] Singapore and San Diego.

He would also like Australian state and federal governments to be more pro-business. “Support more Peter Farrells! Don’t put artificial caps on research and development or amortisation incentives,” he says. “Other governments aren’t thinking that way and so want to partner, support small companies and entrepreneurial companies.

“In California, people fail all the time and get back up again, and people say you are learning.”


Farrell’s tenure at the top of ResMed hasn’t been without its hitches or challenges. There was a clinical trial failure in 2015 when US regulators ruled that a new form of sleep therapy the company was testing endangered patient lives, sending ResMed plummeting 18 per cent.

In 2020, the COVID-19 pandemic disrupted international global supply chains, making it a challenge for ResMed to manufacture and supply customers. Then, governments spanning the US, Singapore, Germany and Australia demanded it supply ventilators to them as it had manufacturing operations in those countries.

There has also been the arrival of new technology, such as wearables and AI, to which the company has had to adapt and capitalise on to keep driving sales.

More recently, the challenge has been the explosion in demand for miracle weight loss drugs such as Ozempic and Mounjaro, often simply known as GLP-1s, which caused a sell-off in the shares of companies such as ResMed. There was some early evidence that those weight loss drugs could also reduce or cure sleep disorders, but this is not proving to be entirely the case.

Farrell has data showing patients going to doctors for weight-loss drugs but also deciding they would address their sleep problems by buying ResMed devices. ResMed’s shares, which are listed on the ASX and the Nasdaq, are now double the price they plunged to in late 2023 on the back of concerns about those weight-loss drugs.

“It might be premature to say they have shrugged off the threat of GLP-1s,” says Wilson Asset Management’s Milne. “This threat remains. But we have come a long way in the last two years, where the hype was at its peak. I believe we are at the very start of the next phase for ResMed, one of customer centricity.”

Getting lucky and staying lucky

Still, unexpected competition and changes in technology are what concern analysts about ResMed’s future, and they, like Milne, are still watching and waiting to see what the full impact of the mass takeup of GLP-1 drugs will be.

In response to those concerns, Farrell likes to quote American business author Jim Collins. “Good luck and bad luck happen to all companies equally, but the successful ones have return on luck,” he says.

A lucky time was when ResMed was able to capitalise on a disastrous product recall by its main rival, Philips, in 2021 due to safety concerns about foam used in one of its products. ResMed swiped Philips’ lost market share as hundreds of millions of devices were recalled, and the gains have been permanent because it has taken Philips years to make the replacement or repair kits.

“We would never have guessed COVID, the supply chain crisis, or GLP-1s,” says Farrell. “We never expected Philips to drop the ball so badly. They have been sent off the field for four years now.”

Farrell is focused on his 2030 strategy, which is to drive high-single digit revenue growth annually, invest 7 per cent of revenue into research and development, and expand ResMed’s sleep offerings by using data to help people battling insomnia. It is also expanding into the fast-growing ventilation and oxygen therapy market.

Farrell’s strategy includes some ambitious targets, which sound like marketing slogans, such as the plan to help 500 million people sleep better. ResMed says 144 million people now use its products, and it has 27 million cloud-connected devices in the market.

ResMed’s investors are backing Farrell and his strategy. “The real strength of a CEO is to take a high-quality business and continue to drive it and improve returns,” says ECP Asset Management’s Dale. “Mick’s been a very good custodian of high-quality assets.”

Bell Direct’s analyst Wulff agrees and sums it up another way. “He has taken what was just a sleep apnoea company into this new monster, which has so many different revenue streams.”

Here is the link:

https://www.afr.com/companies/healthcare-and-fitness/resmed-mick-farrell-cpap-devices-20250724-p5mhm2

A great story of a huge Australian success!

I can remember when Resmed was just an experimental idea being pushed by some friends in the laboratory next to me while I was doing my BSc(Med) in 1970-71.

Rather a pity I did not go and work with them but I had my experiments to do (in my BSc(Med)) and a medical degree to get! Certainly a commercial path not followed – but always watched with interest!

I suspect Resmed has to be the biggest thing ever to come out of Sydney University, as it heads for a market cap. of US 50 Billion

And I was there when it started <grin>!!!

David.

Thursday, August 14, 2025

The Medical Software Industry Association (MSIA) Feel Government Is Hampering Its Efforts….

This appeared a week or so ago.

31 July 2025

Unshackle the medical software industry, MSIA tells Chalmers


By

Staff Writers

The industry is being held back by red tape and a ‘ridiculous burden’ says CEO Emma Hossack.

The Australian medical software industry has warned Treasurer Jim Chalmers ahead of next month’s productivity roundtable to ease the regulatory burden or lose innovation, jobs and profits overseas.

Medical Software Industry Association CEO Emma Hossack said the industry was being held back by red tape.

“The industry standard should be to spend 20% of time working on government approvals and compliance. In the current regulatory environment, it is more like 60% and in some instances as much as 80%,” Ms Hossack said.

“That is a ridiculous burden on the industry.

“The Productivity Commission estimates digital efficiency could save $5 billion a year in public hospital costs alone. That is a conservative number compared to the benefits our industry can provide across the broader medical sector.

“The majority of productivity gains tend to come from technological innovations. We have some incredibly innovative medical software businesses in Australia.

“All we are asking is for the Commonwealth government to release the regulatory shackles.”

The MSIA, which represents about 140 organisations from the medical software industry including Oracle, Telstra Health and Pro Medicus, recently provided a submission on productivity to the new government.

Software from MSIA members provides a range of benefits to the medical sector including reducing duplication of tests and consultations, prevention of the wrong medicines being dispensed, and unnecessary emergency department presentations.

“Without our members, the modern healthcare system doesn’t work,” Ms Hossack said.

“People wouldn’t be able to book an appointment online or medical professionals have quick, easy access to tests and x-ray results.

“We have incredibly talented people in our industry and we want to keep them and their businesses on Australian shores.

“That way they can create more quality jobs here in Australia and increase their growing value to the national economy.

“We look forward to working with the federal government to do our bit in lifting the nation’s productivity levels.”

Here is the link:

https://www.healthservicesdaily.com.au/unshackle-the-medical-software-industry-msia-tells-chalmers/32184

The MSIA claims there ae huge benefits being missed:

17 July 2025

Spend $20m to help save $420m, MSIA tells government


By

Cate Swannell

Time and money is being lost to slow FHIR adoption, but a targeted acceleration program, including an outcomes-based fund, will do wonders.

Here is the link:

https://www.healthservicesdaily.com.au/spend-20m-to-help-save-420m-msia-tells-government/31412

All this sounds wonderful. I wonder if any readers have any concrete examples of such wonderful success to share?

David.